Apollo Medical Holdings, Inc. ("ApolloMed") (OTC-QB: AMEH), an integrated, physician-centric healthcare delivery company, today announced that it has entered into a strategic relationship with Fresenius Medical Care North America (“Fresenius Medical Care”), the nation’s leading provider of products and services for patients with end stage renal disease. The relationship will enable ApolloMed to further develop its risk-oriented, integrated care model in California and expand its “Best in Class” medical management and physician-driven model nationally.

“We are delighted to be partnering with Fresenius Medical Care on delivering a value-driven, integrated care platform that will bring high-quality, cost-effective care to patients,” stated Warren Hosseinion, M.D., Chief Executive Officer of Apollo Medical Holdings. “As the U.S. healthcare system continues to evolve, there is a critical need to develop new integrated care models for seniors and all consumers. ApolloMed is positioned to be a leader of new emerging healthcare delivery companies that are focused on results and patient-centric care and not just administration. I appreciate the confidence that Fresenius Medical Care has in ApolloMed and greatly look forward to expanding our relationship with Fresenius Medical Care and other healthcare leaders on a number of growth initiatives in 2014 and beyond.”

More information can be found in our SEC filings at www.sec.gov.

About Apollo Medical Holdings, Inc. (ApolloMed)

ApolloMed is a leading provider of physician-centric, integrated healthcare management services, fueled by its commitment to provide exceptional multi-disciplinary care in the communities it serves in Southern and Central California. ApolloMed is addressing the healthcare needs of the nation’s largest population center by leveraging its integrated healthcare delivery platform comprised of four affiliated and complementary physician groups: ApolloMed Hospitalists, ApolloMed ACO (Accountable Care Organization), Maverick Medical Group (Independent Physician Association) and ApolloMed Care Clinics. This platform combines hospitalist medicine, critical care medicine, case management and transitional care management that enable healthcare organizations to engage in performance payments for utilization efficiency, quality of care objectives and shared accountability arrangements. ApolloMed strives to improve medical outcomes with high-quality, cost-efficient care. For more information, please visit www.apollomed.net.

Forward Looking Statements

This press release may contain forward-looking statements, including information about management's view of future expectations, plans and prospects for Apollo Medical Holdings, Inc. (“the Company”). In particular, when used in the preceding discussion, the words “predicts,” "believes," "expects," "intends," “seeks,” “estimates,” "plans," "anticipates," and similar conditional expressions or future or conditional verbs such as “will,” “may,” “might,” “should,” “would” and “could” are intended to identify forward-looking statements. In addition, our representatives may from time to time make oral forward-looking statements. Any such statements, other than those of historical fact, about an action, event or development, are forward-looking statements. Such statements are based on the current expectations and certain assumptions of the Company’s management. Such statements are, therefore, subject to a variety of known and unknown risks, uncertainties and other factors, many of which are beyond the control of the Company, which could cause the actual results, performance or achievements of the Company, its subsidiaries and concepts to be materially different than those that may be expressed or implied in such statements or anticipated on the basis of historical trends. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements may vary materially from those described in the relevant forward-looking statement as being expected, anticipated, intended, planned, believed, sought, estimated or projected. Unknown or unpredictable factors also could have material adverse effects on the Company’s future results. The forward-looking statements included herein are made only as of the date hereof. The Company cannot guarantee future results, levels of activity, performance or achievements. Accordingly, you should not place undue reliance on these forward-looking statements. Finally, the Company undertakes no obligation to update or revise these forward-looking statements to reflect the impact of circumstances or events that arise after the date the forward-looking statement was made, except as required by law, and also takes no obligation to update or correct information prepared by third parties that are not paid for by the Company. You should not place undue reliance on any forward-looking statement and should consider the uncertainties and risks discussed under Item 1A. “Risk Factors” of the Company’s Annual Report on Form 10-K for the year ended January 31, 2013 and in any of the Company’s other subsequent Securities and Exchange Commission filings.


Contacts

Apollo Medical Holdings, Inc.
Warren Hosseinion
President and CEO
warrenhoss@apollomed.net
or
Gary Augusta
Executive Chairman
gaugusta@apollomed.net
or
Financial Profiles, Inc.
Jody Cain, 310-478-2700
jcain@finprofiles.com